223P Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish Oncology Group (TOG) s... von Kahraman, S., Erul, E., Gumusay, O., Guven, D.C., Aksoy, S., Basaran, G., Seyyar, M., Sahin, E., Cabuk, D., Bayram, E., Paydas, S., Demirel, B. Çakan, Yaren, A., Gulbagci, B., Hacibekiroglu, I., Baytemur, N. Köse, Demirci, U., Davarci, S.E., Demir, H., Sendur, M.A.N.

Volltext